PATIENTPARTNER
Identifying the Needs for Patients Partnering in Clinical Research
| Coordinatore | VERENIGING SAMENWERKENDE OUDER- EN PATIENTENORGANISATIES
Organization address
address: Vredehofstraat 31 contact info |
| Nazionalità Coordinatore | Netherlands [NL] |
| Sito del progetto | http://www.patientpartner-europe.eu/ |
| Totale costo | 1˙009˙808 € |
| EC contributo | 905˙177 € |
| Programma | FP7-HEALTH
Specific Programme "Cooperation": Health |
| Code Call | FP7-HEALTH-2007-A |
| Funding Scheme | CSA-CA |
| Anno di inizio | 2008 |
| Periodo (anno-mese-giorno) | 2008-05-01 - 2011-04-30 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
VERENIGING SAMENWERKENDE OUDER- EN PATIENTENORGANISATIES
Organization address
address: Vredehofstraat 31 contact info |
NL (SOEST) | coordinator | 0.00 |
| 2 |
EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE
Organization address
address: RUE DE WASHINGTON 40 contact info |
BE (BRUSSELS) | participant | 0.00 |
| 3 |
EUROPEAN GENETIC ALLIANCES' NETWORK
Organization address
address: AVENUE LOUISE 287 contact info |
BE (BRUSSELS) | participant | 0.00 |
| 4 |
GENETIC ALLIANCE UK LTD
Organization address
address: UNIT 4D LEROY HOUSE , ESSEX ROAD 436 contact info |
UK (LONDON) | participant | 0.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'The aim of this 3-year Coordination Action will be to identify the patients’ needs for partnership in the clinical trials context. Moreover, this project will lead to both a well-organized and sustainable communication platform and guidelines to enable the mutual beneficial interactions between patients and clinical trials professionals. This aim will be realized through: I) Interviews, addressing patients (-organizations) that will identify preliminary needs in the clinical trials context from a patients’ perspective. These data are complemented with literature reviews and descriptions of best practices. The combined outcomes will be accessable on a centralized webbased database. II) Subsequent workshops addressing patients (and patient organizations), researchers and scientists, biopharmaceutical companies, regulators and other stakeholders in the clinical trials context. In these workshops, the conclusions from the interviews, literature studies and best practices will be challenged to draw ‘European’ viewpoints and consensus. On the specific website, attendees will be able to consult the outcomes from both the investigational phase and previous workshops. III) The establishment of the European Network of Patients partnering for Clinical Research (EN-PCR). Initially, EN-PCR will be responsible for addressing the high priority issues in this project: paediatric clinical trials, patient registries and biobanks, the Innovative Medicines Initiative (IMI) and ethical issues. Later on, EN-PCR will guarantee the sustainability of this project, being a permanent structure with a bi-directional purpose, both empowering patients and functioning as a one-stop shop for academic and biopharmaceutical research. IV) Further dissemination of the project results will be achieved by a Patient Guide for patient organizations, an Investigator Guide for organizers and sponsors of clinical trials, a List of Recommendations for regulators and a thematic website. The consortium will provide continued support to both EN-PCR and the PatientPartner website after this Coordination Action has ended. This project is implemented by key European and national patient network organisations, and a forum for Good Clinical Practice. It concurrently supports patient-centered clinical research and European biophamaceutical competiveness.'
Altri progetti dello stesso programma (FP7-HEALTH)
GENEGRAFT (2011)
Phase I/II ex vivo gene therapy clinical trial for recessive dystrophic epidermolysis bullosa using skin equivalent grafts genetically corrected with a COL7A1-encoding SIN retroviral vector
Read More